GSK Investigational Site
Ludwigsburg, Baden-Wurttemberg 71640
0 studies enrolling now · 3 studies all time
What they study most
Alzheimer's Disease, Diabetes Mellitus
Studies at this site
- Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus — Completed
- Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers — Stopped early
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease — Completed